HKSE - Delayed Quote
HKD
Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK)
52.200
-0.650
(-1.23%)
At close: November 6 at 4:08:50 PM GMT+8
Loading chart for 1276.HK
- Previous Close
52.850 - Open
52.550 - Bid 52.050 x --
- Ask 52.250 x --
- Day's Range
51.600 - 53.450 - 52 Week Range
43.020 - 80.950 - Volume
2,823,562 - Avg. Volume
5,386,115 - Market Cap (intraday)
346.462B - Beta (5Y Monthly) 0.04
- PE Ratio (TTM)
34.80 - EPS (TTM)
1.500 - Earnings Date --
- Forward Dividend & Yield 0.23 (0.44%)
- 1y Target Est
77.35 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1276.HK
26.64%
SSE Composite Index (000001.SS)
8.05%
1-Year Return
1276.HK
27.70%
SSE Composite Index (000001.SS)
8.95%
3-Year Return
1276.HK
9.37%
SSE Composite Index (000001.SS)
19.32%
5-Year Return
1276.HK
9.37%
SSE Composite Index (000001.SS)
4.51%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
27.04%
-
Return on Assets (ttm)
7.77%
-
Return on Equity (ttm)
13.94%
-
Revenue (ttm)
32.85B
-
Net Income Avi to Common (ttm)
8.88B
-
Diluted EPS (ttm)
1.500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
38.84B
-
Total Debt/Equity (mrq)
0.10%
-
Levered Free Cash Flow (ttm)
1.55B
